药物受理最新动态：Humanwell Pharmaceutical US, Inc.重酒石酸氢...

Group 1 - The application for Hydromorphone Tartrate Extended-Release Tablets by Humanwell Pharmaceutical US, Inc. has been accepted by the National Medical Products Administration on January 13, 2026, with acceptance number JYHL2600002 [1] - The drug type is classified as a chemical drug, and the application type is for import registration under category 5.2 [1] - The companies involved in this application include Humanwell Pharmaceutical US, Inc. and Yichang Humanwell Pharmaceutical Co., Ltd. [1]